Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
Vandecasteele K, Tummers P, Van Bockstal M, De Visschere P, Vercauteren T, De Gersem W, Denys H, Naert E, Makar A, De Neve W. Vandecasteele K, et al. Among authors: de gersem w, de neve w, de visschere p. BMC Cancer. 2018 Sep 17;18(1):898. doi: 10.1186/s12885-018-4800-0. BMC Cancer. 2018. PMID: 30223802 Free PMC article. Clinical Trial.
A Novel Three-dimensional Planning Tool for Selective Clamping During Partial Nephrectomy: Validation of a Perfusion Zone Algorithm.
De Backer P, Vermijs S, Van Praet C, De Visschere P, Vandenbulcke S, Mottaran A, Bravi CA, Berquin C, Lambert E, Dautricourt S, Goedertier W, Mottrie A, Debbaut C, Decaestecker K. De Backer P, et al. Among authors: de visschere p. Eur Urol. 2023 May;83(5):413-421. doi: 10.1016/j.eururo.2023.01.003. Epub 2023 Feb 1. Eur Urol. 2023. PMID: 36737298
Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results.
Tummers P, Makar A, Vandecasteele K, De Meerleer G, Denys H, De Visschere P, Delrue L, Villeirs G, Lambein K, den Broecke RV. Tummers P, et al. Among authors: de meerleer g, de visschere p. Int J Gynecol Cancer. 2013 Jun;23(5):877-83. doi: 10.1097/IGC.0b013e31828d1ec0. Int J Gynecol Cancer. 2013. PMID: 23698797
Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: Analysis of genito-urinary and rectal toxicity.
Sundahl N, De Meerleer G, Villeirs G, Ost P, De Neve W, Lumen N, De Visschere P, Van Eijkeren M, Fonteyne V. Sundahl N, et al. Among authors: de meerleer g, de neve w, de visschere p. Radiother Oncol. 2016 Jun;119(3):398-404. doi: 10.1016/j.radonc.2016.04.031. Epub 2016 May 6. Radiother Oncol. 2016. PMID: 27162160
The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 Patients.
Van Hemelryk A, De Meerleer G, Ost P, Poelaert F, De Gersem W, Decaestecker K, De Visschere P, Fonteyne V. Van Hemelryk A, et al. Among authors: de gersem w, de meerleer g, de visschere p. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):323-332. doi: 10.1016/j.ijrobp.2016.06.011. Epub 2016 Jun 16. Int J Radiat Oncol Biol Phys. 2016. PMID: 27598803 Clinical Trial.
Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.
Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, Van Bockstal M, Van Dorpe J, De Neve W, Denys H, Vandecasteele K. Couvreur K, et al. Among authors: de neve w, de jaeghere e, de visschere p. BMC Cancer. 2018 Nov 12;18(1):1101. doi: 10.1186/s12885-018-5007-0. BMC Cancer. 2018. PMID: 30419851 Free PMC article.
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, Van Dorpe J, Van de Vijver K, Tummers P, Makar A, De Visschere PJL, De Wever O, Amant F, Denys HG, Vandecasteele K. De Jaeghere EA, et al. Among authors: de man k, de wever o, de visschere pjl. Gynecol Oncol. 2020 Nov;159(2):335-343. doi: 10.1016/j.ygyno.2020.08.001. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32859399
Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.
Van Hulle H, Vakaet V, Post G, Van Greveling A, Monten C, Hendrix A, Van de Vijver K, Van Dorpe J, De Visschere P, Braems G, Vandecasteele K, Denys H, De Neve W, Veldeman L. Van Hulle H, et al. Among authors: de neve w, de visschere p. Pilot Feasibility Stud. 2020 Oct 10;6:154. doi: 10.1186/s40814-020-00693-z. eCollection 2020. Pilot Feasibility Stud. 2020. PMID: 33062295 Free PMC article.
Cervical Adenoma Malignum in Third Trimester Pregnancy.
Pannecoeck K, Tummers P, De Visschere P. Pannecoeck K, et al. Among authors: de visschere p. J Belg Soc Radiol. 2021 Jan 6;105(1):2. doi: 10.5334/jbsr.2298. J Belg Soc Radiol. 2021. PMID: 33506174 Free PMC article.
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
Verghote F, Poppe L, Verbeke S, Dirix P, Albersen M, De Meerleer G, Berghen C, Ost P, Villeirs G, De Visschere P, De Man K, De Maeseneer D, Rottey S, Van Praet C, Decaestecker K, Fonteyne V. Verghote F, et al. Among authors: de maeseneer d, de man k, de meerleer g, de visschere p. BMC Cancer. 2021 Oct 18;21(1):1113. doi: 10.1186/s12885-021-08861-x. BMC Cancer. 2021. PMID: 34663254 Free PMC article. Clinical Trial.
93 results